Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational... see more

NDAQ:PMN - Post Discussion

ProMIS Neurosciences Inc > Green on a red day
View:
Post by Thenorth1990 on Mar 30, 2021 1:17pm

Green on a red day

Even on a red day we are green, I guess the last time we were close to clinical trials this had gone 50 cents may be in 2017 to 2018. I really hope we have some surprise earnings to report, they haven't put it out there yet. Generally they post by the 2nd week.
Comment by JoeyBoston on Mar 30, 2021 1:34pm
Huge volume increase & it looks like a lot of new buyers - lots of 50K to 200K share purchases. I'm still buying at these levels. You remove the bankruptcy risk by having very large investors (billionaires) investing, and it makes going to clinical trials a near certainty! Thats a game changer.  Honestly, I'm surprised we haven't seen a double or triple on this news, testing ...more  
Comment by Annayya on Mar 30, 2021 1:39pm
It is interesting that they delayed the earnings so I am hoping for good news as well, but generally the earnings don't move the share price much as the information is mostly financial related with a net loss reported as always. Maybe they will put out a new corporate update with updated info on progress. The estimated earnings for Q4 2020 is on March 31st.  Past few years, it was ...more  
Comment by G1945V on Mar 30, 2021 1:45pm
Earnings ???  G1945V
Comment by M101 on Mar 30, 2021 1:52pm
This frequently goes opposite the market on normal index down days, it's just rotation. But the lack of any serious profit taking on the first leg is why short term technical indicators indicate a strong buy.    
Comment by Thenorth1990 on Mar 30, 2021 2:02pm
I fully agree on that , its just after a long time we have seen some consistent performance. Generally they need like 7mn for yearly operations , not sure how much more clinical trial will add to this. It would be gamechanging if they come up with revenue from serology testing, in my communication with CEO , he mentioned they are trying to achieve something better than existing antibody tests, so ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities